Vijaypd Ceutical IPO

Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services. The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers. The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs. As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations. The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs. This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply. The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications. Competitive Strength: Strengthen its market position by increasing its long-term relationships with its clients. Comprehensive product portfolio. Streamlined supply chain management. Experienced management team with proven execution capabilities.

The Company Vijaypd Ceutical IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (₹ in crores) 1 Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra 10.83 2 Repayment/prepayment of all or certain of the borrowings availed of by the Company 5.10 3 General corporate purposes 0.74

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App